Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sophie Karp

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Micromachines|September 23, 2022
Disease Modeling with Kidney OrganoidsSophie Karp, Martin R Pollak, Balajikarthick Subramanian
Biorxiv : the Preprint Server for Biology|June 25, 2024
Missense Mutant Gain-of-Function Causes Inverted Formin 2 (INF2)-Related Focal Segmental Glomerulosclerosis (FSGS)Balajikarthick Subramanian, Sarah Williams, Sophie Karp, et al.
Science Advances|November 13, 2024
INF2 mutations cause kidney disease through a gain-of-function mechanismBalajikarthick Subramanian, Sarah Williams, Sophie Karp, et al.
Journal of Medical Genetics|February 4, 2022
Dominant negative mutation in oxalate transporter <i>SLC26A6</i> associated with enteric hyperoxaluria and nephrolithiasisNicolas Cornière, R Brent Thomson, Stéphanie Thauvin, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Micromachines|September 23, 2022
Disease Modeling with Kidney OrganoidsSophie Karp, Martin R Pollak, Balajikarthick Subramanian
Biorxiv : the Preprint Server for Biology|June 25, 2024
Missense Mutant Gain-of-Function Causes Inverted Formin 2 (INF2)-Related Focal Segmental Glomerulosclerosis (FSGS)Balajikarthick Subramanian, Sarah Williams, Sophie Karp, et al.
Science Advances|November 13, 2024
INF2 mutations cause kidney disease through a gain-of-function mechanismBalajikarthick Subramanian, Sarah Williams, Sophie Karp, et al.
Journal of Medical Genetics|February 4, 2022
Dominant negative mutation in oxalate transporter <i>SLC26A6</i> associated with enteric hyperoxaluria and nephrolithiasisNicolas Cornière, R Brent Thomson, Stéphanie Thauvin, et al.
Pageof 1